½ÃÀ庸°í¼­
»óǰÄÚµå
1558992

¼¼°èÀÇ SDS Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå °Ö Àü±â¿µµ¿ ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¿¹Ãø(2024-2033³â)

SDS Poly Acrylamide Gel Electrophoresis Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 212 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â ¼¼°è SDS Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå °Ö Àü±â¿µµ¿ ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼­¸¦ ¹ßÇ¥ÇÏ°í ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µî ÁÖ¿ä ½ÃÀå ¿ªÇÐÀ» »ó¼¼ÇÏ°Ô ºÐ¼®Çß½À´Ï´Ù. ÀÌ »ó¼¼ÇÑ º¸°í¼­´Â ½ÃÀå ±¸Á¶¿Í ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀå °¡´É¼º¿¡ ´ëÇØ ¹àÇû½À´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • SDS Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå °Ö Àü±â¿µµ¿ ½ÃÀå ±Ô¸ð(2024³â) : 5¾ï 1,830¸¸ ´Þ·¯
  • ½ÃÀå ¿¹ÃøÄ¡(2033³â) : 8¾ï 2,720¸¸ ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024-2033³â) : 5.3%

SDS Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå °Ö Àü±â¿µµ¿ ½ÃÀå - º¸°í ¹üÀ§:

SDS Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå °Ö Àü±â¿µµ¿(SDS-PAGE)Àº ºÐÀÚ »ý¹°Çаú »ýÈ­Çп¡¼­ ºÐÀÚ·®À» ±âÁØÀ¸·Î ´Ü¹éÁúÀ» ºÐ¸®ÇÏ´Â µ¥ ³Î¸® »ç¿ëµÇ´Â ±â¼úÀÔ´Ï´Ù. ÀÌ ±â¼úÀº ´Ü¹éÁú Á¤·®, È®ÀÎ, Ư¼º ºÐ¼®À» Æ÷ÇÔÇÑ ´Ü¹éÁú ºÐ¼®¿¡ ÇʼöÀûÀÔ´Ï´Ù. ½ÃÀåÀº ÀǾàǰ °³¹ß, Áø´Ü, ±âÃÊ ¿¬±¸ µî ´Ù¾çÇÑ ¿ëµµ¿¡¼­ ´Ü¹éÁú ¿¬±¸ ¼ö¿ä Áõ°¡°¡ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

SDS Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå °Ö Àü±â¿µµ¿ ¼¼°è ½ÃÀå ¼ºÀåÀ» À̲ø°í ÀÖ´Â ÁÖ¿ä ¿äÀÎÀº ¸î °¡ÁöÀÔ´Ï´Ù. ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡¿Í ¸¸¼º ÁúȯÀÇ È®»êÀº °í±Þ ´Ü¹éÁú ºÐ¼® ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ»ê¾÷ÀÇ È®´ë¿Í ´Ü¹éÁúüÇÐÀÇ ¿¬±¸°³¹ßȰµ¿ÀÇ È°¼ºÈ­°¡ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. °Ö Á¦ÇüÀÇ °³¼± ¹× ÀÚµ¿È­ ½Ã½ºÅÛ°ú °°Àº Àü±â¿µµ¿ ½Ã½ºÅÛÀÇ ±â¼úÀû Áøº¸´Â ´Ü¹éÁú ºÐ¼®ÀÇ È¿À²¼º°ú Á¤È®¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Çмú±â°ü ¹× ¿¬±¸±â°ü¿¡¼­ÀÇ SDS-PAGE ä¿ë Áõ°¡°¡ ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:

SDS Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå °Ö Àü±â¿µµ¿ ½ÃÀåÀº ±× ¼ºÀ强¿¡µµ ºÒ±¸ÇÏ°í ¿©·¯ °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ÷´Ü Àü±â ¿µµ¿ ÀåÄ¡ ¹× ½Ã¾à°ú °ü·ÃµÈ ³ôÀº ºñ¿ëÀº ¼Ò±Ô¸ð ¿¬±¸¼Ò ¹× ¿¬±¸ ±â°üÀÇ À庮ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ SDS-PAGE ±â¼úÀÇ º¹À⼺°ú ¼÷·ÃÀÚÀÇ Çʿ伺À¸·Î ÀÎÇØ »ç¿ëÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¶ÇÇÑ Áú·®ºÐ¼®°ú ¿þ½ºÅÏ ºí·ÎÆÃ°ú °°Àº ´ëü ´Ü¹éÁú ºÐ¼®¹ý°úÀÇ °æÀï¿¡ Á÷¸éÇϰí ÀÖÀ¸¸ç, SDS-PAGEÀÇ Ã¤¿ë¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. °Ö ¼º´ÉÀÇ ÆíÂ÷³ª ÀçÇö¼ºÀÇ ¹®Á¦µµ °úÁ¦°¡ µÉ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ:

SDS Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå °Ö Àü±â¿µµ¿ ½ÃÀåÀº ƯÈ÷ °í¼º´É ´Ü¹éÁúüÇÐ¿Í ¸ÂÃãÇü ÀÇ·á ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. º¸´Ù ºü¸£°í Á¤¹ÐÇÑ ½Ã½ºÅÛ °³¹ß°ú °°Àº Àü±â ¿µµ¿ ±â¼úÀÇ Çõ½ÅÀº »õ·Î¿î ¼ºÀåÀÇ ±æÀ» ¼³¸íÇÕ´Ï´Ù. ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö°ú ´Ü¹éÁúüÇк° ÀǾàǰ °³¹ß µî »õ·Î¿î ºÎ¹®¿¡¼­ SDS-PAGEÀÇ ÀÀ¿ë È®´ëµµ »õ·Î¿î ±âȸ¸¦ ±âÀçÇϰí ÀÖ½À´Ï´Ù. Àü±â¿µµ¿ ½Ã½ºÅÛ Á¦Á¶¾÷ü¿Í ¿¬±¸±â°ü °£ÀÇ Àü·«Àû Á¦ÈÞ´Â ½ÃÀå ¼ºÀå°ú ±â¼ú ¹ßÀüÀ» ÃËÁøÇÕ´Ï´Ù. ¶ÇÇÑ Àü±â¿µµ¿±â¼ú°ú ´Ù¸¥ ºÐ¼®¹æ¹ý°úÀÇ À¶ÇÕ¿¡ ÁÖ¸ñÀÌ ¸ð¿© ÀÖ´Â °Íµµ ½ÃÀå È®´ëÀÇ ±âȸ°¡ µË´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • SDS Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå °Ö Àü±â¿µµ¿ ¼¼°è ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • SDS-PAGE ±â¼úÀÇ Ã¤¿ëÀÌ °¡Àå ÁøÇàµÇ°í ÀÖ´Â »ê¾÷°ú Áö¿ªÀº?
  • Àü±â¿µµ¿ ½Ã½ºÅÛÀÇ ¹ßÀüÀº °æÀï ±¸µµ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡´Â°¡?
  • SDS Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå °Ö Àü±â¿µµ¿½ÃÀå¿¡¼­ ¼±µµ ÁøÃâ±â¾÷Àº ´©±¸ÀÌ¸ç ½ÃÀå Æ÷Áö¼ÇÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» ÃëÇϰí Àִ°¡?
  • SDS Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå °Ö Àü±â¿µµ¿ ¼¼°è ½ÃÀå¿¡¼­ÀÇ »õ·Î¿î µ¿Çâ°ú Àå·¡¼ºÀº?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀå ¹üÀ§/ºÐ·ù
  • ½ÃÀåÀÇ Á¤ÀÇ/¹üÀ§/Á¦ÇÑ
  • Æ÷ÇÔ°ú Á¦¿Ü

Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä µ¿Çâ
  • Á¦Ç° Çõ½Å/°³¹ß µ¿Çâ

Á¦4Àå Áß¿äÇÑ ¼º°ø ¿äÀÎ

  • Á¦Ç°ÀÇ Ã¤¿ë/»ç¿ë »óȲ ºÐ¼®
  • Á¦Ç° USP/Ư¡
  • ÃÖ±Ù Á¦Ç° ½ÂÀÎ ¹× ¹ß¸Å
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ½ÃÀå ¹è°æ

  • °Å½Ã°æÁ¦ ¿äÀÎ
  • ¿¹Ãø¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
  • ¿ªÇÐ

Á¦6Àå COVID-19 À§±â - ¿µÇâ Æò°¡

  • COVID-19¿Í ¿µÇ⠺м®
    • Á¦Ç°º°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • Áö¿ªº°
  • 2024³â ½ÃÀå ½Ã³ª¸®¿À

Á¦7Àå ¼¼°è ½ÃÀå ¼ö¿ä(±Ý¾× ¶Ç´Â ±Ô¸ð, 100¸¸ ´Þ·¯) ºÐ¼®

  • °ú°Å ½ÃÀå ¸ÅÃâ(100¸¸ ´Þ·¯) ºÐ¼®, 2019-2023³â
  • ÇöÀç¿Í Àå·¡ ½ÃÀå ¸ÅÃâ(100¸¸ ´Þ·¯) ¿¹Ãø, 2024-2033³â
    • Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
    • Àý´ë ¼öÀÍ ±âȸ

Á¦8Àå Á¦Ç°º° ¼¼°è ½ÃÀå ºÐ¼®

  • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
  • 2019-2023³â Á¦Ç°º° ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ½ÇÀû ºÐ¼®
  • ÇöÀç¿Í Àå·¡ ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Á¦Ç°º°, 2024-2033³â
    • ±â±â
    • ½Ã¾à
    • °Ö
      • ÇÚµåij½ºÆ® °Ö
      • ÇÁ¸®Ä³½ºÆ® °Ö
  • Á¦Ç°º° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦9Àå ÃÖÁ¾ »ç¿ëÀÚº° ¼¼°è ½ÃÀå ºÐ¼®

  • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
  • ÃÖÁ¾ »ç¿ëÀÚº° ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ½ÇÀû ºÐ¼®, 2019-2023³â
  • ÇöÀç¿Í Àå·¡ ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾ »ç¿ëÀÚº°, 2024-2033³â
    • ÀÓ»óÁ¶»ç
    • »ý¸í°øÇаú Á¦¾à¾÷°è
    • Á¤ºÎ±â°ü
    • Çмú±â°ü
  • ÃÖÁ¾ »ç¿ëÀÚº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦10Àå Áö¿ªº° ¼¼°è ½ÃÀå ºÐ¼®

  • ¼Ò°³
  • Áö¿ªº° ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ½ÇÀû ºÐ¼®, 2019-2023³â
  • ÇöÀç¿Í Àå·¡ ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ Áö¿ªº° ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
    • ºÏ¹Ì
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • À¯·´
    • ³²¾Æ½Ã¾Æ
    • µ¿¾Æ½Ã¾Æ
    • ¿À¼¼¾Æ´Ï¾Æ
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • Áö¿ªº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦11Àå ºÏ¹Ì ½ÃÀå ºÐ¼®

Á¦12Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®

Á¦13Àå À¯·´ ½ÃÀå ºÐ¼®

Á¦14Àå ³²¾Æ½Ã¾Æ ½ÃÀå ºÐ¼®

Á¦15Àå µ¿¾Æ½Ã¾Æ ½ÃÀå ºÐ¼®

Á¦16Àå ¿À¼¼¾Æ´Ï¾Æ ½ÃÀå ºÐ¼®

Á¦17Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå ºÐ¼®

Á¦18Àå ½ÃÀå ±¸Á¶ ºÐ¼®

  • ±â¾÷ Tierº° ½ÃÀå ºÐ¼®
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀåÇöÀçºÐ¼®

Á¦19Àå °æÀï ºÐ¼®

  • °æÀï ´ë½Ãº¸µå
  • °æÀï º¥Ä¡¸¶Å·
  • °æÀïÀÇ »ó¼¼
    • Bio-Rad Laboratories, Inc.
    • General Electric Company(GE Healthcare)
    • Merck KGaA(Sigma Aldrich)
    • Thermos Fisher Scientific Inc.
    • Analytik Jena Ag
    • Lonza Group Ltd.
    • Genscript Biotech Corporation
    • Abcam Plc
    • Takara Bio Inc.
    • Amerigo Scientific
    • Promega
    • Cleaver Scientific Ltd.

Á¦20Àå »ç¿ëµÈ ÀüÁ¦Á¶°Ç°ú ¾à¾î

Á¦21Àå Á¶»ç ¹æ¹ý

JHS 24.10.24

Persistence Market Research has recently released a comprehensive report on the global SDS Poly Acrylamide Gel Electrophoresis Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This detailed report sheds light on the market structure and growth potential over the forecast period.

Key Insights:

  • SDS Poly Acrylamide Gel Electrophoresis Market Size (2024E): USD 518.3 Mn
  • Projected Market Value (2033F): USD 827.2 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.3%

SDS Poly Acrylamide Gel Electrophoresis Market - Report Scope:

SDS Poly Acrylamide Gel Electrophoresis (SDS-PAGE) is a widely used technique in molecular biology and biochemistry for separating proteins based on their molecular weight. This technique is crucial for protein analysis, including protein quantification, identification, and characterization. The market is driven by the increasing demand for protein research in various applications, including drug development, diagnostics, and basic research.

Market Growth Drivers:

Several key factors are driving the growth of the global SDS Poly Acrylamide Gel Electrophoresis Market. The increasing focus on personalized medicine and the growing prevalence of chronic diseases are fueling demand for advanced protein analysis techniques. The expanding biopharmaceutical industry, coupled with rising research and development activities in proteomics, is contributing to market growth. Technological advancements in electrophoresis systems, such as improved gel formulations and automated systems, are enhancing the efficiency and accuracy of protein analysis. Additionally, the increasing adoption of SDS-PAGE in academic and research institutions is supporting market expansion.

Market Restraints:

Despite its growth potential, the SDS Poly Acrylamide Gel Electrophoresis Market faces several challenges. High costs associated with advanced electrophoresis equipment and reagents can be a barrier for smaller laboratories and research institutions. Additionally, the complexity of SDS-PAGE techniques and the requirement for skilled personnel may limit its accessibility. The market also faces competition from alternative protein analysis methods, such as mass spectrometry and western blotting, which may impact the adoption of SDS-PAGE. Variability in gel performance and reproducibility issues can also pose challenges.

Market Opportunities:

The SDS Poly Acrylamide Gel Electrophoresis Market presents substantial growth opportunities, particularly with the increasing demand for high-throughput proteomics and personalized medicine. Innovations in electrophoresis technologies, including the development of faster and more accurate systems, offer new growth avenues. Expanding applications of SDS-PAGE in emerging fields such as biomarker discovery and proteomics-based drug development provide additional opportunities. Strategic collaborations between electrophoresis system manufacturers and research institutions can drive market growth and technological advancements. The growing focus on integrating electrophoresis techniques with other analytical methods also presents opportunities for market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the global SDS Poly Acrylamide Gel Electrophoresis Market?
  • Which industries and regions are witnessing the highest adoption of SDS-PAGE technology?
  • How are advancements in electrophoresis systems impacting the competitive landscape?
  • Who are the leading players in the SDS Poly Acrylamide Gel Electrophoresis Market, and what strategies are they implementing to maintain their market positions?
  • What are the emerging trends and future prospects in the global SDS Poly Acrylamide Gel Electrophoresis Market?

Competitive Intelligence and Business Strategy:

Leading players in the SDS Poly Acrylamide Gel Electrophoresis Market, including companies like Bio-Rad Laboratories, Thermo Fisher Scientific, GE Healthcare, Sigma-Aldrich, and Agilent Technologies, are focusing on innovation, research and development, and strategic partnerships to strengthen their market positions. These companies are investing in the development of advanced electrophoresis technologies, enhancing product performance, and expanding their product portfolios. Collaborations with research institutions and investment in new applications of SDS-PAGE are crucial for market penetration and sustained growth. Ensuring compliance with industry standards and regulations, as well as adapting to evolving research needs, helps these companies maintain a competitive edge and achieve long-term success in the SDS Poly Acrylamide Gel Electrophoresis Market.

Key Companies Profiled:

  • Bio-Rad Laboratories, Inc.
  • General Electric Company (GE Healthcare)
  • Merck KGaA (Sigma Aldrich)
  • Thermos Fisher Scientific Inc.
  • Analytik Jena Ag
  • Lonza Group Ltd.
  • Genscript Biotech Corporation
  • Abcam Plc
  • Takara Bio Inc.
  • Amerigo Scientific
  • Promega
  • Cleaver Scientific Ltd.

Key Segments Covered in SDS Poly Acrylamide Gel Electrophoresis Industry Research

Product:

  • Instruments
  • Reagents
  • Gels

End User:

  • Clinical Research
  • Biotechnology and Pharmaceutical Industry
  • Government Agencies
  • Academic Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Recent Product Approval and Launches
  • 4.4. PESTLE Analysis
  • 4.5. Porter's Analysis
  • 4.6. Regulatory Landscape
  • 4.7. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Electrophoresis Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Growth of The Top Companies
    • 5.2.2. Rise in The Protein Quantification Research Projects
    • 5.2.3. Increasing Government Financing and Investment in The Biotech Sector
    • 5.2.4. Research & Development Activities
    • 5.2.5. Increase in Biopharmaceutical Businesses
    • 5.2.6. Mergers and Acquisitions
    • 5.2.7. Growing Adoption of SDS PAGE Products
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By End User
    • 6.1.3. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn ) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn ) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn ) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn ) Analysis By Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Product, 2024-2033
    • 8.3.1. Instruments
    • 8.3.2. Reagents
    • 8.3.3. Gels
      • 8.3.3.1. Handcast Gels
      • 8.3.3.2. Precast Gels
  • 8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn ) Analysis By End User, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By End User, 2024-2033
    • 9.3.1. Clinical Research
    • 9.3.2. Biotechnology and Pharmaceutical Industry
    • 9.3.3. Government Agencies
    • 9.3.4. Academic Institutes
  • 9.4. Market Attractiveness Analysis By End User

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn ) Analysis By Region, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Region, 2024-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. South Asia
    • 10.3.5. East Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn ) Analysis By Market Taxonomy, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Product
    • 11.3.3. By End User
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Product
    • 11.4.3. By End User
  • 11.5. Country Level Analysis & Forecast
    • 11.5.1. U.S. Market Analysis
      • 11.5.1.1. Introduction
      • 11.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 11.5.1.2.1. By Product
        • 11.5.1.2.2. By End User
    • 11.5.2. Canada Market Analysis
      • 11.5.2.1. Introduction
      • 11.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 11.5.2.2.1. By Product
        • 11.5.2.2.2. By End User
  • 11.6. Market Trends
  • 11.7. Key Market Participants - Intensity Mapping
  • 11.8. Drivers and Restraints - Impact Analysis

12. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn ) Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Mexico
      • 12.3.1.3. Argentina
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Product
    • 12.3.3. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By End User
  • 12.5. Country Level Analysis & Forecast
    • 12.5.1. Brazil Market Analysis
      • 12.5.1.1. Introduction
      • 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.1.2.1. By Product
        • 12.5.1.2.2. By End User
    • 12.5.2. Mexico Market Analysis
      • 12.5.2.1. Introduction
      • 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.2.2.1. By Product
        • 12.5.2.2.2. By End User
    • 12.5.3. Argentina Market Analysis
      • 12.5.3.1. Introduction
      • 12.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.3.2.1. By Product
        • 12.5.3.2.2. By End User
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis

13. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn ) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast, By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. France
      • 13.3.1.3. Italy
      • 13.3.1.4. U.K.
      • 13.3.1.5. Spain
      • 13.3.1.6. Russia
      • 13.3.1.7. BENELUX
      • 13.3.1.8. Nordic Countries
      • 13.3.1.9. Rest of Europe
    • 13.3.2. By Product
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By End User
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. Germany Market Analysis
      • 13.5.1.1. Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Product
        • 13.5.1.2.2. By End User
    • 13.5.2. France Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Product
        • 13.5.2.2.2. By End User
    • 13.5.3. Italy Market Analysis
      • 13.5.3.1. Introduction
      • 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.3.2.1. By Product
        • 13.5.3.2.2. By End User
    • 13.5.4. U.K. Market Analysis
      • 13.5.4.1. Introduction
      • 13.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.4.2.1. By Product
        • 13.5.4.2.2. By End User
    • 13.5.5. Spain Market Analysis
      • 13.5.5.1. Introduction
      • 13.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.5.2.1. By Product
        • 13.5.5.2.2. By End User
    • 13.5.6. Russia Market Analysis
      • 13.5.6.1. Introduction
      • 13.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.6.2.1. By Product
        • 13.5.6.2.2. By End User
    • 13.5.7. Nordic Countries Market Analysis
      • 13.5.7.1. Introduction
      • 13.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.7.2.1. By Product
        • 13.5.7.2.2. By End User
    • 13.5.8. BENELUX Market Analysis
      • 13.5.8.1. Introduction
      • 13.5.8.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.8.2.1. By Product
        • 13.5.8.2.2. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn ) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. India
      • 14.3.1.2. Thailand
      • 14.3.1.3. Indonesia
      • 14.3.1.4. Malaysia
      • 14.3.1.5. Rest of South Asia
    • 14.3.2. By Product
    • 14.3.3. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By End User
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. India Market Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Product
        • 14.5.1.2.2. By End User
    • 14.5.2. Thailand Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Product
        • 14.5.2.2.2. By End User
    • 14.5.3. Indonesia Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Product
        • 14.5.3.2.2. By End User
    • 14.5.4. Malaysia Market Analysis
      • 14.5.4.1. Introduction
      • 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.4.2.1. By Product
        • 14.5.4.2.2. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn ) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By End User
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. China Market Analysis
      • 15.5.1.1. Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Product
        • 15.5.1.2.2. By End User
    • 15.5.2. Japan Market Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Product
        • 15.5.2.2.2. By End User
    • 15.5.3. South Korea Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Product
        • 15.5.3.2.2. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn ) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Product
    • 16.3.3. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By End User
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. Australia Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Product
        • 16.5.1.2.2. By End User
    • 16.5.2. New Zealand Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Product
        • 16.5.2.2.2. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn ) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn ) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkiye
      • 17.3.1.3. Northern Africa
      • 17.3.1.4. South Africa
      • 17.3.1.5. Rest of Middle East and Africa
    • 17.3.2. By Product
    • 17.3.3. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By End User
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. GCC Countries Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Product
        • 17.5.1.2.2. By End User
    • 17.5.2. Turkiye Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Product
        • 17.5.2.2.2. By End User
    • 17.5.3. Northern Africa Market Analysis
      • 17.5.3.1. Introduction
      • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.3.2.1. By Product
        • 17.5.3.2.2. By End User
    • 17.5.4. South Africa Market Analysis
      • 17.5.4.1. Introduction
      • 17.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.4.2.1. By Product
        • 17.5.4.2.2. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Benchmarking
  • 19.3. Competition Deep Dive
    • 19.3.1. Bio-Rad Laboratories, Inc.
      • 19.3.1.1. Overview
      • 19.3.1.2. Product Portfolio
      • 19.3.1.3. Key Financials
      • 19.3.1.4. Sales Footprint
      • 19.3.1.5. SWOT Analysis
      • 19.3.1.6. Strategy Overview
        • 19.3.1.6.1. Marketing Strategy
        • 19.3.1.6.2. Product Strategy
        • 19.3.1.6.3. Channel Strategy
    • 19.3.2. General Electric Company (GE Healthcare)
      • 19.3.2.1. Overview
      • 19.3.2.2. Product Portfolio
      • 19.3.2.3. Key Financials
      • 19.3.2.4. Sales Footprint
      • 19.3.2.5. SWOT Analysis
      • 19.3.2.6. Strategy Overview
        • 19.3.2.6.1. Marketing Strategy
        • 19.3.2.6.2. Product Strategy
        • 19.3.2.6.3. Channel Strategy
    • 19.3.3. Merck KGaA (Sigma Aldrich)
      • 19.3.3.1. Overview
      • 19.3.3.2. Product Portfolio
      • 19.3.3.3. Key Financials
      • 19.3.3.4. Sales Footprint
      • 19.3.3.5. SWOT Analysis
      • 19.3.3.6. Strategy Overview
        • 19.3.3.6.1. Marketing Strategy
        • 19.3.3.6.2. Product Strategy
        • 19.3.3.6.3. Channel Strategy
    • 19.3.4. Thermos Fisher Scientific Inc.
      • 19.3.4.1. Overview
      • 19.3.4.2. Product Portfolio
      • 19.3.4.3. Key Financials
      • 19.3.4.4. Sales Footprint
      • 19.3.4.5. SWOT Analysis
      • 19.3.4.6. Strategy Overview
        • 19.3.4.6.1. Marketing Strategy
        • 19.3.4.6.2. Product Strategy
        • 19.3.4.6.3. Channel Strategy
    • 19.3.5. Analytik Jena Ag
      • 19.3.5.1. Overview
      • 19.3.5.2. Product Portfolio
      • 19.3.5.3. Key Financials
      • 19.3.5.4. Sales Footprint
      • 19.3.5.5. SWOT Analysis
      • 19.3.5.6. Strategy Overview
        • 19.3.5.6.1. Marketing Strategy
        • 19.3.5.6.2. Product Strategy
        • 19.3.5.6.3. Channel Strategy
    • 19.3.6. Lonza Group Ltd.
      • 19.3.6.1. Overview
      • 19.3.6.2. Product Portfolio
      • 19.3.6.3. Key Financials
      • 19.3.6.4. Sales Footprint
      • 19.3.6.5. SWOT Analysis
      • 19.3.6.6. Strategy Overview
        • 19.3.6.6.1. Marketing Strategy
        • 19.3.6.6.2. Product Strategy
        • 19.3.6.6.3. Channel Strategy
    • 19.3.7. Genscript Biotech Corporation
      • 19.3.7.1. Overview
      • 19.3.7.2. Product Portfolio
      • 19.3.7.3. Key Financials
      • 19.3.7.4. Sales Footprint
      • 19.3.7.5. SWOT Analysis
      • 19.3.7.6. Strategy Overview
        • 19.3.7.6.1. Marketing Strategy
        • 19.3.7.6.2. Product Strategy
        • 19.3.7.6.3. Channel Strategy
    • 19.3.8. Abcam Plc
      • 19.3.8.1. Overview
      • 19.3.8.2. Product Portfolio
      • 19.3.8.3. Key Financials
      • 19.3.8.4. Sales Footprint
      • 19.3.8.5. SWOT Analysis
      • 19.3.8.6. Strategy Overview
        • 19.3.8.6.1. Marketing Strategy
        • 19.3.8.6.2. Product Strategy
        • 19.3.8.6.3. Channel Strategy
    • 19.3.9. Takara Bio Inc.
      • 19.3.9.1. Overview
      • 19.3.9.2. Product Portfolio
      • 19.3.9.3. Key Financials
      • 19.3.9.4. Sales Footprint
      • 19.3.9.5. SWOT Analysis
      • 19.3.9.6. Strategy Overview
        • 19.3.9.6.1. Marketing Strategy
        • 19.3.9.6.2. Product Strategy
        • 19.3.9.6.3. Channel Strategy
    • 19.3.10. Amerigo Scientific
      • 19.3.10.1. Overview
      • 19.3.10.2. Product Portfolio
      • 19.3.10.3. Key Financials
      • 19.3.10.4. Sales Footprint
      • 19.3.10.5. SWOT Analysis
      • 19.3.10.6. Strategy Overview
        • 19.3.10.6.1. Marketing Strategy
        • 19.3.10.6.2. Product Strategy
        • 19.3.10.6.3. Channel Strategy
    • 19.3.11. Promega
      • 19.3.11.1. Overview
      • 19.3.11.2. Product Portfolio
      • 19.3.11.3. Key Financials
      • 19.3.11.4. Sales Footprint
      • 19.3.11.5. SWOT Analysis
      • 19.3.11.6. Strategy Overview
        • 19.3.11.6.1. Marketing Strategy
        • 19.3.11.6.2. Product Strategy
        • 19.3.11.6.3. Channel Strategy
    • 19.3.12. Cleaver Scientific Ltd.
      • 19.3.12.1. Overview
      • 19.3.12.2. Product Portfolio
      • 19.3.12.3. Key Financials
      • 19.3.12.4. Sales Footprint
      • 19.3.12.5. SWOT Analysis
      • 19.3.12.6. Strategy Overview
        • 19.3.12.6.1. Marketing Strategy
        • 19.3.12.6.2. Product Strategy
        • 19.3.12.6.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦